Levi & Korsinsky notifies investors that it has commenced an investigation into Synchrony Financial (NYSE: SYF) concerning potential violations of the federal securities laws.
Synchrony issued a press release on January 28, 2025, announcing its financial results for the fourth quarter of 2024. Among other items, Synchrony's earnings for the quarter missed consensus estimates, as the Company's net interest income was weaker than expected, its provision for credit card losses exceeded analyst estimates, and its net charge-off rate rose. Following this news, Synchrony's stock price fell sharply during intraday trading on the same day.
If you suffered a loss on your Synchrony Financial securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired XPLR Infrastructure, LP (NYSE: XIFR) securities.
If you suffered a loss on your XPLR Infrastructure, LP investment and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
THE LAWSUIT: Jan 26 2021 - Jan 27 2025
CASE DETAILS: The filed complaint alleges that XPLR Infrastructure, LP made materially false and/or misleading statements and/or failed to disclose that: (i) XPLR was struggling to maintain its operations as a yieldco; (ii) defendants temporarily relieved this issue by entering into CEPF, convertible equity portfolio financing arrangements while downplaying the attendant risks; (iii) XPLR could not buy out CEPFs before their maturity date without risking significant unitholder dilution; (iv) as a result, defendants planned to halt cash distributions to investors and instead redirect those funds to, inter alia, buy out the Company’s CEPFs; (v) as a result of all the foregoing, XPLR’s yieldco business model and distribution growth rate was unsustainable; and (vi) as a result, defendants’ public statements were materially false and misleading at all relevant times.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Midland States Bancorp, Inc. (NASDAQ: MSBI) concerning potential violations of the federal securities laws.
Midland States Bancorp announced its financial results for the fourth quarter of 2024 on January 23, 2025. Among other items, the Company reported a loss of $2.52 per diluted share, falling short of the Zacks Consensus Estimate of $0.70 and representing a significant year-over-year decline from earnings of $0.89 per share in the fourth quarter of 2023. Following this news, Midland States Bancorp's stock price fell over 20% on January 24, 2025.
If you suffered a loss on your Midland States Bancorp, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Spyre Therapeutics, Inc. (NASDAQ: SYRE) concerning potential violations of the federal securities laws.
On November 18, 2024, Spyre disclosed in a filing with the U.S. Securities and Exchange Commission "that the Company's previously issued audited consolidated financial statements as of December 31, 2023 and for the year and the second and third quarter interim periods within the year then ended, and its unaudited consolidated financial statements for the quarterly and year-to-date (as applicable) periods ended March 31, 2024, June 30, 2024 and 2023, and September 30, 2024 and 2023 (collectively, the ‘Affected Financial Statements' and such periods, the ‘Affected Periods') should no longer be relied upon" due to "a misapplication of Generally Accepted Accounting Principles in the United States . . . as it relates to the Company's exclusion of its Series A and Series B non-voting convertible preferred stock in the calculation of basic and diluted net loss per share and a finding of material weakness in internal control over financial reporting solely related to such matter." Accordingly, Spyre advised that it "intends to file amendments to the Annual Report on Form 10-K and each of the Quarterly Reports on Form 10-Q for the Affected Periods to correct the net loss per share figures as soon as possible." Following this news, Spyre's stock price drastically fell during intraday trading on November 19, 2024.
If you suffered a loss on your Spyre Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Electronic Arts Inc. (NASDAQ: EA) concerning potential violations of the federal securities laws.
On January 22, 2025, EA issued a press release pre-announcing their preliminary Q3 FY25 results and announcing a guide-down from the company’s prior expectations. Where “EA’s initial guidance for fiscal year 2025 anticipated mid-single-digit growth in live services net bookings … the company now projects a mid-single-digit decline.” EA primarily pointed to two setbacks: Global Football, specifically EA Sports FC 25, which required “a comprehensive gameplay refresh” earlier this month; and Dragon Age, which engaged approximately 1.5 million players during the quarter, down nearly 50% from the company’s expectations.” Following this news, EA’s stock price fell by $24.12 per share and is currently trading at $118.23 per share.
If you suffered a loss on your Electronic Arts Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Construction Partners, Inc. (NASDAQ: ROAD) concerning potential violations of the federal securities laws.
On January 23, 2025, Spruce Point Capital Management published a report highlighting the increasing pressures faced by Construction Partners suggesting that the share price could have a 35-50% potential long-term downside risk. The Spruce Point report focused on Construction Partners’ major decline in contracts from its largest customer, Florida Department of Transportation, and a weak expansion into Texas, which was portrayed as a strong acquisition for the company. The report concluded that the market had miscalculated Construction Partners’ enterprise value, which in turn, reflects a misunderstanding of the company’s business and financial prospects, thus, predicting the 35-50% downside potential. Following this news, Construction Partners’ stock price plummeted over 8% to open at $85.17 per share on January 23, 2025
If you suffered a loss on your Construction Partners, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Triumph Financial, Inc. (NASDAQ: TFIN) concerning potential violations of the federal securities laws.
On January 22, 2025, after market close, Triumph published a quarterly earnings report stating that it had a profit of $0.13 per share, missing the Zacks Consensus Estimate of $0.26 per share by 50%. Triumph CEO Aaron Graft also stated that first quarter 2025 earnings are expected to be even lower, operating expenses are expected to increase, and that the company does not anticipate material revenue will be generated from recently announced initiatives during the first half of 2025. Following this news, Triumph’s stock price fell 3.6% to open at $88.70 per share on January 23, 2025.
If you suffered a loss on your Triumph Financial, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into JinkoSolar Holding Co., Ltd. (NYSE: JKS) concerning potential violations of the federal securities laws.
JinkoSolar issued a press release on January 17, 2025, reporting "estimates for certain preliminary unaudited financial results" for 2024 for "its majority-owned principal operating subsidiary, Jinko Solar Co., Ltd." Among other items, JinkoSolar estimated 2024 net income in the range of 80 million yuan to 120 million yuan ($10.92 million to $16.37 million), equating to a decline of more than 98%. JinkoSolar also expects to report full-year preliminary unaudited net loss attributable to shareholders excluding extraordinary gains and losses in the range of 750 million yuan to 1.05 billion yuan, representing a decrease of 100.8% to 115.2%. Following this news, JinkoSolar's American depositary receipt ("ADR") price fell over 9% on the same day.
If you suffered a loss on your JinkoSolar Holding Co., Ltd. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into CECO Environmental Corp. (NASDAQ: CECO) concerning potential violations of the federal securities laws.
CECO issued a press release on January 16, 2025, "announc[ing] preliminary financial results for the fourth quarter and full year 2024 and provid[ing] an update on further portfolio transformation." Among other items, CECO lowered its 2024 revenue guidance to the range of $555 million to $558 million, compared to its previous guidance of $575 million to $600 million. CECO also announced its intent to divest its Fluid Handling business by the end of the first quarter of 2025 and to use the sale proceeds to pay down debt and position the Company's balance sheet for future strategic growth investments. Following this news, CECO's stock price fell over 7% on January 17, 2025.
If you suffered a loss on your CECO Environmental Corp. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Agilysys, Inc. (NASDAQ: AGYS) concerning potential violations of the federal securities laws.
On January 21, 2025, after the market closed, Agilysys issued a press release announcing third quarter revenue below expectations and the company’s own guidance, resulting in a significant revision to Agilysys’ FY25 revenue guidance. CEO Srinivasan admitted they “underestimated the sales challenges on the point-of-sale POS side of the equation,” that the year “could have been a lot better,” and that they “could have also done a lot better with the speed of hiring for the implementation services teams.” Following this news, on January 22, 2024, Agilysys’ stock price fell by $25.23 per share to close at $100.67 per share.
If you suffered a loss on your Agilysys, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into IGM Biosciences, Inc. (NASDAQ: IGMS) concerning potential violations of the federal securities laws.
IGM issued a press release on January 9, 2025, "announc[ing] a strategic update to halt further development of imvotamab, an IgM-based CD20 X CD3 bispecific antibody T cell engager, and IGM-2644, an IgM-based CD38 X CD3 bispecific antibody T cell engager, for autoimmune diseases." The press release quoted Mary Beth Harler, M.D., the Company's Chief Executive Officer, as stating that "[i]nterim data from the Phase 1b studies of imvotamab in rheumatoid arthritis and systemic lupus erythematosus show that the depth and consistency of B cell depletion is insufficient to meet our high bar for success[.]" Following this news, IGM's stock price fell over 66% on January 10, 2025.
If you suffered a loss on your IGM Biosciences, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Polestar Automotive Holding UK PLC (NASDAQ: PSNY) concerning potential violations of the federal securities laws.
On January 16, 2025, Polestar filed a report with the U.S. Securities and Exchange Commission (SEC). The report, a Form 6-K, revealed that the company had identified errors in its previously reported financial statements. These errors affect the audited financial reports for the years ending December 31, 2022, and December 31, 2023, as well as unaudited financial reports for interim periods between September 30, 2022, and June 30, 2024. Polestar announced that it would need to restate these financial documents, including the interim financials for the six-month periods ending June 30, 2023, and June 30, 2024. Following this news, Polestar's Class A American Depositary Shares (ADS) fell over 11% during intraday trading on the same day.
If you suffered a loss on your Polestar Automotive Holding UK PLC securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Signet Jewelers Limited (NYSE: SIG) concerning potential violations of the federal securities laws.
On January 14, 2025, Signet issued a press release announcing the company’s holiday sales results, comprising the 10-week period ending January 11, 2025, and significantly underperformed compared to expectations. Signet blamed the underperformance on a slump in fashion gifting “as consumers gravitated to lower price points even more than anticipated in a continued competitive environment.” Due to the impact of the company’s poor holiday performance, Signet reduced its guidance across the board for the current fourth quarter of fiscal year 2025. Following this news, Signet’s stock price fell by $17.98 per share and is currently trading at $56.06 per share.
If you suffered a loss on your Signet securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Johnson & Johnson (NYSE: JNJ) concerning potential violations of the federal securities laws.
J&J issued a press release on January 8, 2025, announcing that "on January 5, out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and all U.S. VARIPULSE™ cases while we investigate the root cause of four reported neurovascular events in the U.S. External Evaluation." Following this news, J&J's stock price fell over 2% on the same day.
If you suffered a loss on your Johnson & Johnson securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into MicroCloud Hologram Inc. (NASDAQ: HOLO) concerning potential violations of the federal securities laws.
On January 8, 2025, MicroCloud and several other quantum computing stocks, fell drastically after Nvidia CEO Jensen Huang stated that "very useful quantum computers" are likely 20 years away. Following this news, MicroCloud stock fell over 30% on the same day.
If you suffered a loss on your MicroCloud Hologram Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Rigetti Computing, Inc. (NASDAQ: RGTI) concerning potential violations of the federal securities laws.
On January 8, 2025, Rigetti and several quantum computing stocks, fell drastically after Nvidia CEO Jensen Huang stated that "very useful quantum computers" are likely 20 years away. Following this news, Rigetti stock fell over 45% on the same day.
If you suffered a loss on your Rigetti Computing, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Inspired Entertainment, Inc. (NASDAQ: INSE) concerning potential violations of the federal securities laws.
Inspired Entertainment, Inc., a gaming technology company, announced on November 8, 2023, that it had discovered accounting errors in its financial statements dating back to January 1, 2021, primarily related to the capitalization of software development costs under U.S. GAAP standards. These errors required the company to restate its financial results for these periods, and thus, Inspired Entertainment delayed releasing its third-quarter 2023 financial results to address the issue. The Audit Committee of the Board of Directors of the Company then determined that the Company’s financial statements, including press releases, earnings statements, investor presentations, and issued reports, made January 1, 2021, and onwards, should no longer be relied upon and require restatement. A broader review of the company’s accounting practices is underway, with input from its current independent accounting firm, though the extent of further adjustments remains unclear. Following this news, the price of Inspired Entertainment shares fell over 29% on November 9, 2023.
If you suffered a loss on your Inspired Entertainment, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Carvana Co. (NYSE: CVNA) concerning potential violations of the federal securities laws.
On January 2, 2025, Carvana became the subject of a report published by Hindenburg Research. The report, titled: "Carvana: A Father-Son Accounting Grift For The Ages," alleges that the Company's turnaround is a "mirage." The report claims, "Our research uncovered $800 million in loan sales to a suspected undisclosed related party, along with details on how accounting manipulation and lax underwriting have fueled temporary reported income growth - all while insiders cash out billions in stock." The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
If you suffered a loss on your Carvana Co. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Vail Resorts, Inc. (NYSE: MTN) concerning potential violations of the federal securities laws.
Seeking Alpha reported on January 2, 2025, that Vail shares "have come under increased selling pressure . . . as the strike by 200 members of the Park City Professional Ski Patrol Association continues without a satisfactory offer from the company", which "has now garnered support from ski patrols at Vail Resorts' other locations." Seeking Alpha further reported that "[t]o keep the slopes open during the holiday week, Vail Resorts . . . has reassigned patrollers from its Breckenridge, Crested Butte, and Keystone resorts to fill in for striking members at Park City", but that "by transferring patrol from one resort to another, the company risks damaging workforce morale and creating an unsafe environment for guests." Following this news, Vail Resorts' stock price fell over 6% on the same day.
If you suffered a loss on your Vail Resorts, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Dave Inc. (NASDAQ: DAVE) concerning potential violations of the federal securities laws.
Morningstar reported on December 31, 2024, that Dave recently announced updates to its fee structure in response to issues raised in the FTC's lawsuit, which was amended by the DOJ earlier this week. According to Morningstar, the FTC, initially filed a complaint in November 2024, accusing Dave of misleading marketing practices related to its cash advance services. According to Morningstar, on December 30, 2024, the DOJ amended its complaint to include Dave's CEO, Jason Wilk, as a named defendant. The amended complaint alleges that Dave and its CEO engaged in deceptive practices by imposing hidden fees and using a misleading app interface that encouraged users to provide substantial tips without offering a transparent option to avoid tipping. The DOJ is seeking civil penalties in the case. Following this news, shares of Dave Inc. stock fell over 10% during intraday trading on December 31, 2024.
If you suffered a loss on your Dave Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Sangamo Therapeutics, Inc. (NASDAQ: SGMO) concerning potential violations of the federal securities laws.
Sangamo announced on December 30, 2024, that Pfizer, with whom the Company was co-developing hemophilia A gene therapy candidate giroctocogene fitelparvovec, would be returning after the development and commercialization rights to giroctocogene fitelparvovec after deciding not to pursue commercialization of the asset, which is in phase 3. Sangamo stated in a press release announcing this development, that it was "surprised and extremely disappointed by Pfizer's decision" to end the collaboration so close to anticipated Biologics License Application and Marketing Authorisation Application submissions for giroctocogene fitelparvovec, which the Company had expected to occur in early 2025. The collaboration and license agreement with Pfizer will terminate effective April 21, 2025, at which time Pfizer will be required to transition the giroctocogene fitelparvovec program back to Sangamo. Following this news, Sangamo's stock price fell during intraday trading on December 31, 2024.
If you suffered a loss on your Sangamo Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Walmart Inc. (NYSE: WMT) concerning potential violations of the federal securities laws.
The Consumer Financial Protection Bureau ("CFPB") announced on December 23, 2024, that it had filed a lawsuit against Walmart and Branch Messenger for forcing delivery drivers to use costly deposit accounts to get paid and for deceiving workers-"last mile" drivers in Walmart's Spark Driver program-about how they could access their earnings. The CFPB's lawsuit alleges that Walmart and Branch opened Branch accounts for Spark Drivers, and Walmart then deposited drivers' pay into these accounts, without the drivers' consent. According to the CFPB, Walmart told Spark Drivers that they were required to use Branch to get paid and that they would terminate workers who did not want to use these accounts. Further, Walmart and Branch also misled workers about the availability of same-day access to their earnings. In addition, in a press release announcing the lawsuit, the CFPB stated that "[d]rivers had to follow a complex process to access their funds, and when they finally did, they faced further delays or fees if they needed to transfer the money they earned into an account of their choice. This resulted in workers paying more than $10 million in fees to transfer their earnings to an account of their choice." Following this news, Walmart's stock price fell sharply during intraday trading on the same day.
If you suffered a loss on your Walmart Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into XBiotech Inc. (NASDAQ: XBIT) concerning potential violations of the federal securities laws.
XBiotech announced on December 23, 2024, that it was pausing a phase 2 rheumatoid arthritis program after the candidate, Natrunix, failed to meet its primary endpoint. Specifically, the Company noted that "substantial irregularities that make unequivocal interpretation of the findings difficult." Following this news, XBiotech's stock price sharply fell during intraday trading on the same day.
If you suffered a loss on your XBiotech Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) concerning potential violations of the federal securities laws.
On December 19, 2024, the company reported disappointing results from its RewinD-LB Phase 2b clinical trial for the pain drug suzetrigine. The trial, which targeted pain caused by a pinched nerve in the spine, showed no significant difference in pain reduction compared to a placebo. The company also announced plans to proceed with a Phase 3 trial for suzetrigine, a decision that has left some analysts questioning the rationale. One commentator stated on X "Vertex often gets the benefit of the doubt given its track record, but damn, this one is tough to reconcile." The company's announcements come mere days after insider transactions have been reported. Following this news, shares of Vertex fell 12% in morning trading on the same day.
If you suffered a loss on your Vertex Pharmaceuticals securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Sezzle Inc. (NASDAQ: SEZL) concerning potential violations of the federal securities laws.
On December 18, 2024, Hindenburg Research accused the company of engaging in unsustainable lending practices funded by high-interest loans, overstating its customer and merchant base, and allowing insiders to profit through margin loans. Hindenburg Research's report raises concerns regarding Sezzle’s financial health, and Sezzle's business model. Following this news, shares of Sezzle fell over 22% on the same day.
If you suffered a loss on your Sezzle Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Sapiens International Corporation N.V. (NASDAQ: SPNS) concerning potential violations of the federal securities laws.
On November 8, 2024, Sapiens International reported 3Q 2024 earnings that fell well below expectations and then lowered its guidance for the year and predicted single-digit revenue growth for 2025. Management attributed the decrease to continued delays in deal closings, a larger-than-anticipated impact from clients moving to SaaS solutions from on-premises solutions, and an increase in competition in North America. Analysts expressed concerns regarding the Company’s weak performance in North America, noting a decline in revenue growth as the SaaS transition and economic uncertainty is leading to longer sales cycles. Following this news, SPNS’s stock price fell by $10.35 per share, or approximately 26.24% to close at $29.10 per share.
If you suffered a loss on your Sapiens International Corporation N.V. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Enovix Corporation (NASDAQ: ENVX) concerning potential violations of the federal securities laws.
Analysts expressed concerns about the timing of the company’s early November $100 million public offering announcement. The equity offering was announced shortly after management stated on a Q3 2024 earnings call that the firm had no immediate capital needs. Following the sudden departure of Enovix CFO Farhan Ahmad, shares of Enovix fell over 6% on December 16, 2024.
If you suffered a loss on your Enovix Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Keros Therapeutics, Inc. (NASDAQ: KROS) concerning potential violations of the federal securities laws.
Keros issued a press release on December 12, 2024, "announc[ing] that it has voluntarily halted dosing in the 3.0 mg/kg and 4.5 mg/kg treatment arms in the ongoing TROPOS trial, a Phase 2 clinical trial of cibotercept (KER-012) in combination with background therapy in patients with pulmonary arterial hypertension ("PAH"), based on a safety review due to the unanticipated observation of pericardial effusion adverse events in the trial." Following this news, Keros's stock price fell sharply during intraday trading on the same day.
If you suffered a loss on your Keros Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Genuine Parts Company (NYSE: GPC) concerning potential violations of the federal securities laws.
On October 22, 2024, Genuine reported 3Q 2024 earnings that fell well below expectations and then lowered its guidance for the year. Management attributed the decrease to weakness in Europe and challenges in its industrial segment. Analysts expressed concern at the Company’s “anemic industrial sales” as well as flat growth in automotive sales. Following this news, GPC’s stock price fell by $30.01 per share, or approximately 21% to close at $113.11 per share.
If you suffered a loss on your Genuine Parts Company securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Informa TechTarget (NASDAQ: TTGT) concerning potential violations of the federal securities laws.
TechTarget completed its business combination on December 2, 2024, with Informa Tech, a business unit of Informa PLC ("Informa"). On December 6, 2024 Tech Target disclosed in a filing with the U.S. Securities and Exchange Commission that Informa's management had advised the Company that certain "financial statements previously prepared by Informa should no longer be relied upon and were being restated because of errors identified by Informa in such financial statements". Following this news, TechTarget's stock price fell over 8% on December 9, 2024.
If you suffered a loss on your Informa TechTarget securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Conagra Brands, Inc. (NYSE: CAG) concerning potential violations of the federal securities laws.
On October 2, 2024, Conagra reported 1Q 2025 financial results that reported a decrease in net sales. The Company attributed the lost sales to a “manufacturing disruption” at its Hebrew National hot dog plant. Analysts expressed concern and surprise at the Company’s decrease in organic sales growth. Following this news, CAG’s stock price fell by $2.64 per share, or approximately 8% to close at $30.08 per share.
If you suffered a loss on your Conagra Brands, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Paladin Energy Ltd (OTC: PALAF) concerning potential violations of the federal securities laws.
Paladin issued an announcement on November 12, 2024, entitled "Langer Heinrich Mine update and revision of FY2025 guidance." In this announcement, Paladin said that "[a]s a result of the lower than expected production results for October, and noting the ongoing challenges and operational variability experienced to date in ramping up production at the [Langer Heinrich Mine], Paladin has determined to revise its FY2025 production guidance to 3.0 - 3.6 Mlb (previously 4.0 - 4.5 Mlb) and withdraw all other guidance in relation to FY2025." Following this news, Paladin stock fell over 24% on the same day.
If you suffered a loss on your Paladin Energy Ltd securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) concerning potential violations of the federal securities laws.
On December 10, 2024, Dave & Buster's reported that "Chris Morris, the Company's Chief Executive Officer ("CEO"), has tendered his resignation as CEO and Director to pursue other interests. The Board has been working with Heidrick & Struggles, a global executive search firm, for the last few months to assist in identifying the Company's next permanent CEO and has already started meeting potential candidates." Following this news, Dave & Buster's stock fell over 14% intraday on December 11, 2024.
If you suffered a loss on your Dave & Buster's Entertainment, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired DMC Global Inc. (NASDAQ: BOOM) securities.
If you suffered a loss on your DMC Global Inc. investment and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
THE LAWSUIT: May 03 2024 - Nov 04 2024
CASE DETAILS: The filed complaint alleges that DMC Global Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the goodwill associated with Acadia products was overstated due to the adverse events and circumstances affecting that reporting segment; (ii) DMC Global’s materially inadequate internal systems and processes were adversely affecting its operations; (iii) the Company’s inadequate systems and processes prevented it from ensuring reasonably accurate guidance and that its public disclosures were timely, accurate, and complete; (iv) as a result, defendants misrepresented DMC Global’s operations and financial results; and/or (v) as a result, the Company’s public statements were materially false, misleading, or lacked a reasonable basis when made.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Winnebago Industries, Inc. (NYSE: WGO) concerning potential violations of the federal securities laws.
On September 23, 2024, Hunterbrook Media published an article called "'Grand Deception'- Winnebago Muzzles Outcry Over Major Problem That Owners Say Makes RVs Dangerous, Untowable, Worthless." In this article, Hunterbrook said Winnebago's "best-selling Grand Design RVs" appear to be "experiencing frame failure, potentially affecting thousands of units sold for more than a billion dollars. This defect has led to costly damage and potential safety hazards, and rendered some RVs unroadworthy." Further, the article stated "Winnebago has used NDAs, buybacks, and online censorship to silence complaints about frame failure[.]" Following this news, Winnebago's stock fell over 2% on the same day.
If you suffered a loss on your Winnebago Industries, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Airship AI Holdings, Inc. (NASDAQ: AISP) concerning potential violations of the federal securities laws.
Airship AI issued a press release on November 14, 2024, reporting its financial and operational results for the third quarter of 2024. Among other items, Airship AI reported revenue of $2.9 million, missing consensus estimates by $1.9 million. In the press release, President Paul Allen stated that the Company "saw several large opportunities pushed out to FY 2025 or drastically cut due to budget challenges across several federal agencies" and that "the completion of the capital raise late in the quarter caused delays in bringing in several opportunities as the funds were needed to cover the cost of goods sold for those opportunities." Following this news, Airship AI's stock price fell over 22% on November 15, 2024.
If you suffered a loss on your Airship AI Holdings, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Cato Corporation (NYSE: CATO) concerning potential violations of the federal securities laws.
Cato issued a press release on November 22, 2024, stating that "[i]n light of the current economic conditions and current sales trends the Board of Directors of [Cato] suspended the regular quarterly dividend." Following this news, Cato's stock price fell sharply during intraday trading.
If you suffered a loss on your The Cato Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Macy's, Inc. (NYSE: M) concerning potential violations of the federal securities laws.
Macy's issued a press release on November 25, 2024, announcing its preliminary third-quarter 2024 results. Therein, Macy's disclosed that "during the preparation of its unaudited condensed consolidated financial statements for the fiscal quarter ended November 2, 2024, it identified an issue related to delivery expenses in one of its accrual accounts" and "consequently initiated an independent investigation." Macy's reported that "[a]s a result of the independent investigation and forensic analysis, the company identified that a single employee with responsibility for small package delivery expense accounting intentionally made erroneous accounting accrual entries to hide approximately $132 to $154 million of cumulative delivery expenses from the fourth quarter of 2021 through fiscal quarter ended November 2, 2024." Macy's further advised that "[t]he individual who engaged in this conduct is no longer employed by the company." Following this news, Macy's stock price fell sharply during intraday trading on the same day.
If you suffered a loss on your Macy's, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Oklo Inc. (NYSE: OKLO) concerning potential violations of the federal securities laws.
Kerrisdale Capital published a short report on Oklo on November 20, 2024, which it described as "a $3B nuclear energy company that went public via SPAC six months ago - with no regulator-approved design, no revenue for years, and no proven commercial viability for its planned 15-50 MWe microreactors." The Kerrisdale report asserted that Oklo faces massive technical and financial challenges" in its quest to become the owner-operator of hundreds of nuclear "powerhouses" and that "[i]n classic SPAC fashion, Oklo has sold the market on inflated unit economics while grossly underestimating the time and capital it will take to commercialize its product. . . . Virtually every aspect of Oklo's investment case warrants skepticism." Following this news, Oklo's stock price fell over 3% on the same day.
If you suffered a loss on your Oklo Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Target Corporation (NYSE: TGT) concerning potential violations of the federal securities laws.
On November 20, 2024, Target reported earnings well below Wall Street's expectations, which the big retail chain blamed on slower-than-expected demand. Target executives cited continued weakness in discretionary sales, which include things like apparel and consumer electronics, as well as costs tied to the short-lived ports strike. Following this news, Target's shares dropped over 15% in premarket trading.
If you suffered a loss on your Target Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Arvinas, Inc. (NASDAQ: ARVN) concerning potential violations of the federal securities laws.
On May 1, 2025, Arvinas issued a press release announcing a re-prioritization of its vepdegestrant development plan and research portfolio. Management also announced it was initiating cost reductions, including cutting approximately one-third of its workforce. Following this news, ARVN’s stock price fell by $2.39 per share, or approximately 25% to close at $7.23 per share.
If you suffered a loss on your Arvinas securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Codere Online Luxembourg, S.A. (NASDAQ: CDRO) concerning potential violations of the federal securities laws.
Codere issued a press release on November 18, 2024, announcing receipt of "a staff determination letter . . . , from the Listing Qualifications Department of The Nasdaq Stock Market LLC (‘Nasdaq'), notifying the Company of the determination from the Nasdaq Staff (the ‘Staff') to delist the Company's securities from The Nasdaq Stock Market, given the Company had not filed its Form 20-F for the year ended December 31, 2023 . . . in accordance with continued Listing Rule 5250(c)(1)[.]" Following this news, Codere's stock price declined sharply during intraday trading on November 19, 2024.
If you suffered a loss on your Codere Online Luxembourg, S.A. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Incyte Corporation (NASAQ: INCY) concerning potential violations of the federal securities laws.
On November 18, 2024, INCY announced it will pause enrollment in the Phase 2 study of its drug INCB000262 in chronic spontaneous urticaria (CSU) due to “the observation of certain in vivo preclinical toxicology findings.” The Company also announced the discontinuation of the development of its drug INCB000547 for patients with cholestatic pruritus (CP). Both of these drugs stem from Incyte’s $750 million acquisition of Escient Pharmaceuticals earlier this year. Following this news, Incyte’s stock price fell by $9.05 per share, or approximately 12% to close at $67.92 per share.
If you suffered a loss on your Incyte Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Quanterix Corporation (NASDAQ: QTRX) concerning potential violations of the federal securities laws.
After the market closed, on November 12, 2024, Quanterix announced that it had “identified an error regarding the capitalization of labor and overhead costs applied to prior periods, dating back to at least 2021,” which had affected the valuation of its inventory. As a result, the company stated that the financial statements reflecting these errors should no longer be relied upon. Following this news, Quanterix’s stock price fell over 18% on November 13, 2024.
If you suffered a loss on your Quanterix Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Neurogene Inc. (NASDAQ: NGNE) concerning potential violations of the federal securities laws.
Neurogene issued a press release on November 11, 2024, reporting "interim clinical data in the first four participants in the low-dose cohort of its ongoing Phase 1/2 open-label trial designed to evaluate NGN-401 gene therapy for the treatment of female pediatric patients with Rett syndrome." Although Neurogene characterized the data as "positive", one of two patients given a high dose reported an emerging treatment-related serious adverse event that the Company described as "consistent with known risks of [adeno-associated virus] gene therapy[.]" Following this news, Neurogene's stock price fell over 44% on November 12, 2024.
If you suffered a loss on your Neurogene Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Clear Secure, Inc. (NYSE: YOU) concerning potential violations of the federal securities laws.
On November 7, 2024, Clear published its third quarter results, reporting a slowdown in new users of its annual membership service. Active Clear Plus members grew only 0.8% in the quarter, the smallest gain in over two years. This slowdown comes on the back of price increases that have seen family prices increase 70% year over year from $70 to $119. Following this news, Clear’s stock price fell by $9.92 per share to close at $28.53 per share.
If you suffered a loss on your Clear Secure, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Universal Display Corporation (NASDAQ: OLED) concerning potential violations of the federal securities laws.
On October 30, 2024, Universal announced 3Q 2024 revenue results that fell short of consensus and lowered its CY2024 revenue guidance. Analysts questioned the continued delay and lack of an “explicit timeline” in the commercial availability of its phosphorescent blue emissive system. Following this news, OLED’s stock price fell by $22.84 per share, or approximately 12% to close at $180.32 per share.
If you suffered a loss on your Universal Display Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Proficient Auto Logistics, Inc. (NASDAQ: PAL) concerning potential violations of the federal securities laws.
On October 16, 2024, Proficient Auto Logistics issued a report pertaining to anticipated operating and financial metrics for the third quarter of fiscal year 2024. The Company stated that they estimated revenue for the third quarter to be in the range of $90 to $92 million, reflecting a decrease of 14 to 16% relative to the combined revenue of the third quarter of 2023. Following this news, the Company's stock dropped over 28% in the subsequent trading session.
If you suffered a loss on your Proficient Auto Logistics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Coursera, Inc. (NYSE: COUR) concerning potential violations of the federal securities laws.
On April 29, 2024, Coursera reported 1Q 2024 financial results that missed revenue estimates and then lowered its full-year guidance. Management attributed this decrease to “demand softening” in North America and “delays in a new content launch.” Analysts commenting on the issue mention the failure of Coursera’s artificial intelligence (AI) products to drive stronger financial results. Following this news, COUR’s stock price fell by $1.67 per share, or approximately 14% to close at $10.22 per share.
If you suffered a loss on your Coursera, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Celanese Corporation (NYSE: CE) concerning potential violations of the federal securities laws.
On November 4, 2024, Celanese issued a press release reporting its financial results for the third quarter of 2024. Celanese's reported earnings adjusted for one-time items in the third quarter were $2.44 per share, compared with a consensus estimate of $2.84 per share. Celanese also reported revenue of $2.65 billion, representing a 2.6% year-over-year decline and falling short of consensus estimates of $2.69 billion. In the press release, Celanese's Chief Executive Officer stated that "[i]n the third quarter, we faced a severely constrained demand environment that, in some cases like auto, degraded swiftly" and cautioned investors that "[w]e expect demand conditions to worsen in the fourth quarter, as automotive and industrial segments react to recent dynamics by seasonally destocking at heavier than normal levels." Following this news, Celanese's stock price fell over 26% on November 5, 2024.
If you suffered a loss on your Celanese Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into First Northwest Bancorp (NASDAQ: FNWB) concerning potential violations of the federal securities laws.
On October 25, 2024, FNWB announced that its previously reported financial results for the second quarter of 2024 could no longer be relied upon due to an additional $6.6 million in charge-offs and a higher provision for consumer loans. As a result, the company restated its total provision for credit losses on loans to $8.7 million. FNWB also revealed that a material weakness existed in its internal controls over financial reporting as of June 30, 2024. Following this news, FNWB’s stock price dropped over 2% on October 28, 2024.
If you suffered a loss on your First Northwest Bancorp securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Viking Therapeutics, Inc. (NASDAQ: VKTX) concerning potential violations of the federal securities laws.
On November 3, 2024, Viking released positive trial data for VK2735, the Company's anti-obesity drug, as part of a presentation at the Obesity Week medical meeting, causing Viking's stock price to climb 9% during intraday trading on November 4, 2024. However, analysts were quick to note that Viking may face production problems for VK2735, especially for 100mg or higher doses. Analysts at Deutsche Bank stated in a note that scaling up production for the drug "will be costly with capital requirements and expertise beyond what [Eli] Lilly (LLY) and Novo [Nordisk] (NVO) currently have[.]" Following this news, Viking's stock price fell over 13% on November 4, 2024.
If you suffered a loss on your Viking Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Este Lauder Companies Inc. (NYSE: EL) concerning potential violations of the federal securities laws.
On October 31, 2024, Estée Lauder issued a press release announcing its fiscal 2025 first quarter results. Among other items, Estée Lauder reported revenue of $3.36 billion, missing consensus estimates and representing a decline of 4.5% from the same period in the prior year. Estée Lauder attributed the results to "worsened consumer sentiment in China" and "lower replenishment orders in Asia travel retail," among other factors. The Company declared a quarterly dividend of $0.35 per share, a reduction of its previous quarterly dividend of $0.66 per share. Following this news, Estée Lauder's stock price fell over 20% on the same day.
If you suffered a loss on your The Este Lauder Companies Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Bancorp, Inc. (NASDAQ: TBBK) concerning potential violations of the federal securities laws.
On October 24, 2024, Bancorp issued a press release announcing its financial results for the third quarter of 2024. Among other items, Bancorp reported GAAP earnings per share of $1.04, missing consensus estimates by $0.08. The Company attributed the disappointing results to the addition of "a new a new CECL factor . . . which increased the provision for credit losses and resulted in an after-tax reduction in net income of $1.5 million"; "[p]rior period interest income reversals on real estate bridge loans transferred to nonaccrual or modified, [which] resulted in an after-tax reduction in net income of $1.2 million"; and "[a] loss resulting from a transaction processing delay [which] increased non-interest expense and resulted in an after-tax reduction in net income of approximately $900,000." Following this news, Bancorp's stock price fell over 14% on October 25, 2024.
If you suffered a loss on your The Bancorp, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Enphase Energy, Inc. (NASDAQ: ENPH) concerning potential violations of the federal securities laws.
On October 22, 2024, Enphase issued a press release announcing its financial results for the third quarter of 2024. Among other items, Enphase reported weaker than expected earnings and revenue, and forecast fourth quarter revenues that fell short of analyst expectations. Guggenheim downgraded Enphase to Sell from Neutral, noting that the Company "is losing share to Chinese competitors who are willing to sell at less than half Enphase's level." Following this news, Enphase's stock price fell over 14% on October 23, 2024.
If you suffered a loss on your Enphase Energy, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into CECO Environmental Corp. (NASDAQ: CECO) concerning potential violations of the federal securities laws.
On October 29, 2024, CECO issued a press release announcing its financial results for the third quarter of 2024. Among other items, CECO reported non-GAAPP earnings per share of $0.14, missing consensus estimates by $0.06, and revenue of $135.51 million, representing a 9.3% decline year-over-year and missing consensus estimates by $20.43 million. In the press release, CECO's Chief Executive Officer stated that "[w]e were disappointed that we fell short of the anticipated quarterly revenue and income outlook as a handful of customer-driven delays in larger projects could not be overcome by continued progress with margin expansion and other actions." Following this news, CECO's stock price fell over 14% on the same day.
If you suffered a loss on your CECO Environmental Corp. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Huntington Ingalls Industries, Inc. (NYSE: HII) concerning potential violations of the federal securities laws.
On October 31, 2024, Huntington Ingalls reported Q3 earnings that fell considerably short of analyst estimates, including a 34.2% miss on EPS. The Company's gross and operating margins both also fell from the same quarter in the previous year. Following this news, Huntington Ingalls stock fell over 26% on that same day.
If you suffered a loss on your Huntington Ingalls Industries, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Myriad Genetics, Inc. (NASDAQ: MYGN) concerning potential violations of the federal securities laws.
On October 31, 2024, it was revealed that UnitedHealth Group ("UnitedHealth") would no longer cover GeneSight, Myriad's genetic test to help determine which mental health medications are likely to work with an individual patient, beginning January 1, 2025. Specifically, market analysts reported that a document from UnitedHealth stated that the coverage is ending as tests for behavioral health, which includes GeneSight, are "unproven" and "not medically necessary." Following this news, Myriad's stock price fell over 18% on November 1, 2024.
If you suffered a loss on your Myriad Genetics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Janus International Group, Inc. (NYSE: JBI) concerning potential violations of the federal securities laws.
Janus issued a press release on October 29, 2024 announcing its financial results for its fiscal third quarter. The release disclosed, in part, revenue of $230.1 million, representing a year-over-year decline of 17.9%, and missing consensus estimates by $18.11 million. Further, Janus updated its full-year revenue guidance to a range of $910 million to $925 million, compared to consensus estimates of $1 billion, citing headwinds from macroeconomic factors, interest rate uncertainty, and persistent project delays. On this news, Janus's stock price fell almost 30% to close at $7.24 per share on October 29, 2024.
If you suffered a loss on your Janus securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Applied Materials, Inc. (NASDAQ: AMAT) concerning potential violations of the federal securities laws.
On October 15, 2024, the investment research firm Hedgeye added Applied Materials as a new short idea, claiming to have "tested [management's] conclusions" with respect to the Company's growth "and found it may not look as good as it seems," and asserting that "[f]rom a financial comparison, [Applied Materials] actually look[s] the worst among its peers in several categories[.]" Following this news, Applied Materials' stock price fell over 10% on the same day .
If you suffered a loss on your Applied Materials, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





